HUTCHMED (China) Ltd (FRA:H7T1)
€ 16.4 -0.7 (-4.09%) Market Cap: 2.80 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 4.05 GF Score: 66/100

Full Year 2018 Hutchison China MediTech Ltd Earnings Call Transcript

Mar 11, 2019 / 01:00PM GMT
Operator

Hello, and welcome to the Chi-Med 2018 Full Year Financial Results. My name is Molly, and I'll be your coordinator for today's event. (Operator Instructions) Please note that this call is being recorded. (Operator Instructions)

I will now hand you over to your host, Mr. Christian Hogg, CEO to begin today's conference. Thank you.

Christian Hogg
Hutchison China MediTech Limited - CEO & Executive Director

Okay. Thank you. Thanks very much, Molly. Welcome everybody to the 2018 full year results conference call for Chi-Med. If I draw your attention to the presentation, if you go through the disclaimer on Page 2 to Page 4, we can start to talk about the 2018 financial results.

So Page 4, just as a reminder, of the 3 sort of core areas of our focus. Actually, before I go into this, I'd just remind everybody that on our side, we have Dr. Weiguo Su, our Chief Scientific Officer; and also Johnny Cheng, our Chief Financial Officer; as well as myself. So back to Page 4. We're very focused on trying to build a science-focused global biopharmaceutical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot